BEA TECHNOLOGIES S.p.A.

CONSTANT INNOVATION: BEA Technologies is a leader in the production of filter elements with high capacity and membranes for the purification of chemical-pharmaceutical products, liquid and viscous products.

In the field of filtration and purification for pharmaceutical applications, BEA Technologies, an Italian company with a consistent international network, has a consistent experience in the production of customized filters and products as the membrane filters in NYLON 66 with positive charge to retain Endotoxins.

BEA Technologies, an Italian company with a consistent international presence, is one of  the leaders in Europe in the production of membrane filters and filters with nanofibers for the filtration of liquid solutions and "critical" products as the NYLON 66 – positive charged membrane filters.

The company is able to offer the most suitable products for the solution of a wide range of specific filtration problems, which can also be customized on the basis of the most challenging customer needs. Among the proposed filtration solutions, high-performance filtration systems for the pharmaceutical sector have been developed, in particular the line of filter elements POSINYL that are made with positive charged NYLON 66 membranes with high capacity to retain endotoxins and POSITRAK for very fine particles.


The Italian company meets the demands of the pharmaceutical sector: “We offer a series of filters, specific for pharmaceutical applications”, declares Mr. Roberto Bea, President of BEA Technologies, who considers Research and Development processes as the key to success. “Our purpose is to become a leader of the European market in the supply of filtration products specific for this sector; our efforts are dedicated to design new filters to satisfy the request of our pharmaceutical customers and to be recognized as significant players worldwide.”

Among the solutions proposed by the company, which in recent years has focused on the application of Positive charged filters and nanofibers for the pharmaceutical industry, new high-performance filtration systems and products are announced.


BEA Technologies offers three series of filter elements with nanofibers called MAGNEX, NANOTRAK and NOVATRAK, that meet the needs of companies engaged in the production of new generation drugs (which have a high degree of sensitivity during the production process).


For the purification of viscous products and solutions (as gelatine based products) BEA Technologies has developed the MAGNEXFLO automatic filtration system which can retain even small particles and make the solution very clear and ready to be used for additional process steps. The scope is to ensure optimal automatic filtration in demanding situations as the purification of "critical" or viscous products.

In addition, for specific pharma processes, which are not permitting the presence of “animal substance”, we are producing the BEAPURE series of “ANIMAL-FREE” which are assembled using “animal-free” certified materials and polymers (besides the BSE/TSE safety requirements) to guarantee any possibility of contact between the pharma products with tallow-derived additives, often present in various polymers.

Critical microfiltration products are produced in a controlled atmosphere environment (clean room) and in compliance with the GMP guidelines, to ensure a high level of quality and cleanliness for biological applications.

“In 1981, we were one of the first companies in Italy to install a clean room for the production of filter elements", says Mr. Roberto Bea. “Of course, the cleanroom has been constantly adapted to the changing needs; the last major innovation in 2011, when we completed the expansion and modernization of the production spaces and a new expansion of production capacity is planned for 2024. We believe that filtration processes are increasingly essential to ensure the high quality of products on the market"

Discover more on www.bea-italy.com

Bea Technologies Spa

Phone +39 02 339 271  |  Fax +39 02 339 0713  |  info@bea-italy.com  |  www.bea-italy.com

Phone +39 02 339 271  |  Fax +39 02 339 0713
info@bea-italy.com  |  www.bea-italy.com

02/23/2024 23:27:17
  • Home | Cover
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Controlant
  • Syntegon
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Datwyler Company Insight
  • Datwyler
  • CfPIE
  • In Depth
  • Dawn of a new indication: How to study drugs for aging 
  • Cleanroom tech tackles environmental impact of consumables
  • Tapping into digital therapeutics to improve neurological outcomes
  • CMO Moves: Regulatory catalysts for drug manufacturing – March
  • Ethics of ultra-rare disease drug development and expanded access
  • APAC early-stage innovators raise one-third less VC funds than US players
  • Zenatek Company Insight
  • BEA Technologies
  • Bio Image Systems Inc.
  • Thematic Take
  • Thematic Take: contents
  • Foreword: the transformative power of cloud
  • An introduction to cloud computing
  • A history of cloud computing
  • The impact of cloud computing on the pharmaceutical industry 
  • Applications of cloud computing in the pharmaceutical industry
  • Latest news: cloud computing in pharma
  • Q&A with GlobalData thematic analyst
  • Is RFID the future of smart labelling?
  • Cloud robotics labs are accelerating drug discovery and development
  • Leading pharma companies in the cloud computing theme
  • Deal activity related to cloud in the pharmaceutical industry since 2020
  • Cloud hiring trends in the global pharmaceutical industry since 2020
  • Cloud patent applications in the global pharmaceutical industry since 2020
  • Mentions of cloud in pharmaceutical industry company filings since 2020
  • GlobalData Thematic Intelligence
  • Pharma Sponsored Supplements
  • HOF Sonderanlagenbau
  • Thermo Fisher Scientific
  • Listings
  • Events
  • Rankings
  • Buyer's Guides
  • Next issue
03/27/2023 00:00:00